Alnylam Pharmaceuticals, Inc. (ALNY) Reports Q4 Loss of $0.33

Go back to Alnylam Pharmaceuticals, Inc. (ALNY) Reports Q4 Loss of $0.33
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Delayed: 242.61 --0 (-0%)
Previous Close $242.61    52 Week High $109.10 
Open $242.61    52 Week Low $31.38 
Day High $242.61    P/E N/A 
Day Low $242.61    EPS $-1.45 
Volume 229